Tumor Ablation Market Worth $515.2 Million by 2020

DALLAS, June 29, 2015 /PRNewswire/ --

According to a new market research report "Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecasts to 2020", published by MarketsandMarkets, the global Tumor Ablation Market Is Poised to Reach $515.2 Million by 2020, growing at a CAGR of 11.5% from 2015 to 2020.

Browse 72 market data Tables and 86 Figures spread through 330 Pages and in-depth TOC on "Tumor Ablation Market"

http://www.marketsandmarkets.com/Market-Reports/tumor-ablation-market-142550258.html

Early buyers will receive 10% customization on this report. 

Based on technology, the global Tumor Ablation Market is classified into four major segments, namely, radiofrequency ablation, microwave ablation, cryoablation, and other technologies (including irreversible electroporation, radioiodine, HIFU, and laser ablation).

Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=142550258

On the basis of mode of treatment, the global Tumor Ablation Market is classified into surgical ablation, laparoscopic ablation, and percutaneous ablation. The global Tumor Ablation Market is further classified into five application segments, namely, liver cancer, lung cancer, kidney cancer, bone metastasis, and others (includes cancer of prostate, breast, colorectal, neuroendocrine, head, neck, and lumbar vertebrae).

Factors such as growing geriatric population across the world, increasing population base of cancer patients, technological advancements in ablation devices, increasing number of hospitals and surgical and ablation centers, increasing demand for minimally invasive cancer treatment procedures, and growing awareness regarding the benefits offered by ablation procedures over those of conventional therapeutic and surgical procedures are fuelling the growth of the global Tumor Ablation Market. On the other hand, cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors hampering the growth of this market.

As of 2015, North America is expected to hold the largest share of the Tumor Ablation Market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period (2015 to 2020). This can be attributed to factors such as large population base paired with high prevalence and incidence of various cancers (such as liver, lung, and kidney cancer), ongoing government initiatives for development and modernization of healthcare infrastructure, increasing adoption due to continuously decreasing device price associated with tumor ablation products, and rising trend of localized manufacturing due to growing focus of global giants in the APAC market. Medtronic, plc (U.S.), AngioDynamics, Inc. (U.S.), HealthTronics, Inc. (U.S.), Galil Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), EDAP TMS S.A. (France), NeuWave Medical Inc. (U.S.), Mermaid Medical A/S (Denmark), SonaCare Medical, LLC (U.S.), and Misonix, Inc. (U.S.) are the major players in the global Tumor Ablation Market.

Browse Related Reports: 

Ablation Technologies Market - by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019.

http://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html

Electrophysiology Market - by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ICE, X-ray)) & Indication (AF, VT, WPW) - Global Forecasts to 2019.

http://www.marketsandmarkets.com/Market-Reports/electrophysiology-market-200003281.html

About MarketsandMarkets: 

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets